IM
IMV (renamed Immunovaccine)
IMV·NASDAQDartmouth CAFounded 200030 employees
Micro CapbiotechPublicOncologyInfectious Disease
Platform: DPX Immuno
Market Cap
$0.03B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (IMV)
Loading IMV stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| IMV-1446 | IMV-1446 | Approved | 2 | MDM2 | CRC | ||
| Surazumab | IMV-5744 | Preclinical | 2 | FLT3 | MMADPKD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (6)